Stay updated on AAV2/6 Gene Therapy SB-525 in Severe Hemophilia A Clinical Trial
Sign up to get notified when there's something new on the AAV2/6 Gene Therapy SB-525 in Severe Hemophilia A Clinical Trial page.

Latest updates to the AAV2/6 Gene Therapy SB-525 in Severe Hemophilia A Clinical Trial page
- ChecktodayNo Change Detected
- Check8 days agoChange DetectedThe web page has been updated from version 2.16.1 to version 2.16.2.SummaryDifference0.1%
- Check15 days agoChange DetectedThe web page has been updated to indicate that the ClinicalTrials.gov data ingest will be modernized in June 2025, allowing API users to provide input before implementation. Additionally, the revision number has been updated from v2.15.2 to v2.16.1.SummaryDifference2%
- Check22 days agoNo Change Detected
- Check44 days agoChange DetectedThe web page has been updated from version 2.15.0 to version 2.15.2.SummaryDifference0.1%
- Check51 days agoChange DetectedThe page now includes a new section with helpful links provided by Pfizer for obtaining contact information for nearby study centers.SummaryDifference1.0%
- Check58 days agoChange DetectedThe webpage has been updated to include new information about the SB-525 study, specifically regarding dose selection based on safety and kinetics of FVIII levels, and it has been revised to version 2.15.0. Notably, significant details about the study's purpose and methodology have been removed.SummaryDifference23%
- Check65 days agoChange DetectedThe web page has been updated from version 2.14.3 to version 2.14.4.SummaryDifference0.1%
Stay in the know with updates to AAV2/6 Gene Therapy SB-525 in Severe Hemophilia A Clinical Trial
Enter your email address, and we'll notify you when there's something new on the AAV2/6 Gene Therapy SB-525 in Severe Hemophilia A Clinical Trial page.